Hypercalciuria

Approximately 77,000 people in the U.S. have hypoparathyroidism due to absent or subphysiological levels of parathyroid hormone.

Preventive pharmacological therapy may help to reduce reoccurring symptoms in patients with urolithiasis and hypercalciuria, according to data from a retrospective cohort study.